These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 8131364)
1. Clinical trials of natural surfactant extract in respiratory distress syndrome. Mercier CE; Soll RF Clin Perinatol; 1993 Dec; 20(4):711-35. PubMed ID: 8131364 [TBL] [Abstract][Full Text] [Related]
2. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. Ardell S; Pfister RH; Soll R Cochrane Database Syst Rev; 2015 May; (5):CD000144. PubMed ID: 26009996 [TBL] [Abstract][Full Text] [Related]
3. Neonatal respiratory distress syndrome and surfactant therapy; a brief review. Robertson B Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999 [TBL] [Abstract][Full Text] [Related]
4. Clinical trials of synthetic surfactant in the respiratory distress syndrome of premature infants. Corbet A Clin Perinatol; 1993 Dec; 20(4):737-60. PubMed ID: 8131365 [TBL] [Abstract][Full Text] [Related]
5. Controversies: synthetic or natural surfactant treatment for respiratory distress syndrome? The case for synthetic surfactant. Whitelaw A J Perinat Med; 1996; 24(5):427-35. PubMed ID: 8950722 [TBL] [Abstract][Full Text] [Related]
7. Choosing a right surfactant for respiratory distress syndrome treatment. Ramanathan R Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858 [TBL] [Abstract][Full Text] [Related]
8. History of surfactant from 1980. Halliday HL Biol Neonate; 2005; 87(4):317-22. PubMed ID: 15985754 [TBL] [Abstract][Full Text] [Related]
9. Lucinactant for the prevention of respiratory distress syndrome in premature infants. Jordan BK; Donn SM Expert Rev Clin Pharmacol; 2013 Mar; 6(2):115-21. PubMed ID: 23473590 [TBL] [Abstract][Full Text] [Related]
10. A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome. Walti H; Monset-Couchard M Drug Saf; 1998 May; 18(5):321-37. PubMed ID: 9589844 [TBL] [Abstract][Full Text] [Related]
11. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants]. de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193 [TBL] [Abstract][Full Text] [Related]
12. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome. Reynolds MS; Wallander KA Clin Pharm; 1989 Aug; 8(8):559-76. PubMed ID: 2670398 [TBL] [Abstract][Full Text] [Related]
13. Exogenous surfactant use in neonates. Ishisaka DY Ann Pharmacother; 1996 Apr; 30(4):389-98. PubMed ID: 8729894 [TBL] [Abstract][Full Text] [Related]